Vir Biotechnology
VIR
VIR
142 hedge funds and large institutions have $2.11B invested in Vir Biotechnology in 2020 Q4 according to their latest regulatory filings, with 44 funds opening new positions, 55 increasing their positions, 25 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
6.81% more ownership
Funds ownership: 55.14% → 61.95% (+6.8%)
12% less capital invested
Capital invested by funds: $2.41B → $2.11B (-$293M)
23% less call options, than puts
Call options by funds: $10.9M | Put options by funds: $14.3M
Holders
142
Holding in Top 10
5
Calls
$10.9M
Puts
$14.3M
Top Buyers
| 1 | +$53.7M | |
| 2 | +$36.8M | |
| 3 | +$23.7M | |
| 4 |
Voloridge Investment Management
Jupiter,
Florida
|
+$9.4M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$9.01M |
Top Sellers
| 1 | -$6.85M | |
| 2 | -$3.17M | |
| 3 | -$2.95M | |
| 4 |
Nuveen Asset Management
Chicago,
Illinois
|
-$2.56M |
| 5 |
GGHC
Gilder Gagnon Howe & Co
New York
|
-$1.85M |